Welcome to LookChem.com Sign In|Join Free

CAS

  • or

25452-29-3

Post Buying Request

25452-29-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25452-29-3 Usage

Type of compound

Secondary amine, member of the phenylpropanolamine family.

Usage

Commonly used in organic synthesis and pharmaceutical research for introducing the benzylamine moiety into molecules.

Physical appearance

Colorless to pale yellow liquid.

Odor

Mild.

Solubility

Soluble in most organic solvents.

Safety precautions

Handle and store with caution, as it can be harmful if inhaled, ingested, or absorbed through the skin. May cause irritation to the eyes, skin, and respiratory tract.

Check Digit Verification of cas no

The CAS Registry Mumber 25452-29-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,4,5 and 2 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 25452-29:
(7*2)+(6*5)+(5*4)+(4*5)+(3*2)+(2*2)+(1*9)=103
103 % 10 = 3
So 25452-29-3 is a valid CAS Registry Number.

25452-29-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(4-methoxyphenyl)methylamino]-2-methylpropan-1-ol

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25452-29-3 SDS

25452-29-3Relevant articles and documents

HIV Integrase Inhibitors

-

Page/Page column 50, (2009/10/17)

The disclosure generally relates to the novel compounds of formula I, including their salts, which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

Reductive Cleavage of Aryl Oxazolines to Benzaldehydes and Substituted Toluenes

Meyers, A. I.,Himmelsbach, Richard J.,Reuman, Michael

, p. 4053 - 4058 (2007/10/02)

Aryl oxazolines have been converted to their corresponding benzaldehydes and toluenes by several routes by passing through the intermediate amino alcohols.The transformations proceeded under mild conditions and were shown to be generally applicable to a variety of substitutions on the aromatic nucleus.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 25452-29-3